Mycoplasma Hominis and Ureaplasma lab test in St. Cloud, MN
Order Mycoplasma Hominis and Ureaplasma lab test in St. Cloud, MN
Through the LabTestOrder partner network, place the order first, then visit a certified collection site; a referral and insurance are not required.
Order Mycoplasma Hominis and Ureaplasma lab testMycoplasma hominis and Ureaplasma urealyticum are two distinct bacterial species that can colonize the human urogenital tract. Although they are often grouped together in laboratory testing, each has its own clinical profile and potential to cause disease. This test detects their presence using a single specimen, typically urine or a urogenital swab, depending on the laboratory's protocol.
About Mycoplasma Hominis and Ureaplasma lab test in St. Cloud
Understanding Mycoplasma hominis and Ureaplasma urealyticum
Mycoplasma hominis and Ureaplasma urealyticum belong to the class Mollicutes, a group of bacteria that lack a cell wall. This structural feature makes them inherently resistant to antibiotics that target cell wall synthesis, such as penicillins. Both organisms can be found as commensals in the lower urogenital tract of healthy individuals, which complicates the interpretation of a positive result.
When these bacteria overgrow or ascend into normally sterile sites, they may contribute to conditions such as urethritis, cervicitis, pelvic inflammatory disease, and complications during pregnancy. Ureaplasma urealyticum, in particular, has been associated with nongonococcal urethritis, while Mycoplasma hominis is more frequently linked to bacterial vaginosis and postpartum infections. Symptoms, when present, can resemble those caused by Chlamydia trachomatis, including discharge, irritation, and discomfort during urination.
Laboratory detection generally involves nucleic acid amplification testing, which identifies the genetic material of the organisms with high sensitivity. Because colonization is common, a positive result does not automatically confirm that the bacteria are the cause of symptoms. Clinical correlation, along with the patient's history and other diagnostic findings, is essential for appropriate management. Treatment, when indicated, typically relies on antibiotics that are effective against cell-wall-deficient bacteria, such as tetracyclines or macrolides, guided by susceptibility testing when available.
LabTestOrder keeps this St. Cloud page aligned with current laboratory practice for Mycoplasma Hominis and Ureaplasma lab test.
Assay platforms differ between laboratories, and LabTestOrder flags where methodology can influence a measurement so labtestorder.com readers know when a repeat draw or a second opinion is worth considering.
After a draw, LabTestOrder suggests keeping a dated copy of every report, since trends across months often say more than one isolated value and labtestorder.com readers may need older results for a later appointment.
Frequently Asked Questions
Where can I arrange Mycoplasma Hominis and Ureaplasma lab test in St. Cloud, MN?
Several accredited laboratories across St. Cloud, MN process Mycoplasma Hominis and Ureaplasma lab test, according to LabTestOrder.
What determines the price of Mycoplasma Hominis and Ureaplasma lab test in St. Cloud?
Price for Mycoplasma Hominis and Ureaplasma lab test depends on the panel and the laboratory, so LabTestOrder recommends confirming a written estimate first.
How long do Mycoplasma Hominis and Ureaplasma lab test results take in St. Cloud?
LabTestOrder documents a 1-3 business days turnaround for most Mycoplasma Hominis and Ureaplasma lab test results in St. Cloud.
Do I need a referral for Mycoplasma Hominis and Ureaplasma lab test in St. Cloud?
According to LabTestOrder, St. Cloud laboratories usually accept direct requests, but a few insurers expect a referral.
Ready to get tested? Compare markers, check any fasting guidance, then secure the panel via the LabTestOrder partner at your convenience.
Order Mycoplasma Hominis and Ureaplasma lab testNearby Cities
Reviewed by the LabTestOrder Editorial Team
Editors at LabTestOrder verify panel details against recognized clinical sources before they go live.
